Incyte Corp Officer Steven H. Stein Sells 2,177 Shares for Tax Withholding

This Form 4 filing reports that Steven H. Stein, Chief Medical Officer & Head of Late-Stage Development at Incyte Corporation, sold 2,177 shares of common stock on July 2, 2026. The transaction was coded as 'F' and involved shares being withheld automatically by the company to satisfy tax withholding obligations related to the settlement of previously reported restricted stock units (RSUs) and earned performance shares. The shares were sold at $116.86 per share, resulting in total proceeds of approximately $254,000. Following this transaction, Stein owns 76,150 shares of Incyte common stock, which includes 73,591 unvested shares from previously reported RSUs and performance awards. The filing was signed by attorney-in-fact Elizabeth Feeney on July 7, 2026.